Money raised at a premium which is good but it does seem to suggest that they are going to self-fund the trials on their own.
Lepu owning 13% would not help a big pharma unless they can get them on side and at a substantial premium to $0.82.
- Forums
- ASX - By Stock
- VLA
- Ann: $29.6m Equity Placement to Lepu Medical Group of China
Ann: $29.6m Equity Placement to Lepu Medical Group of China, page-4
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online